Leo Ehrlich - Dec 30, 2022 Form 4 Insider Report for Innovation Pharmaceuticals Inc. (IPIX)

Role
CEO and Chairman, Director
Signature
/s/ Leo Ehrlich
Stock symbol
IPIX
Transactions as of
Dec 30, 2022
Transactions value $
$0
Form type
4
Date filed
1/4/2023, 03:15 PM
Previous filing
Sep 28, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction IPIX Class B Common Stock Other $0 -11.3M -72.29% $0.00 4.33M Dec 30, 2022 Class A Common Stock 11.3M Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The Class B Common Stock is convertible into Class A Common Stock at any time on a one-for-one basis, and has no expiration date.
F2 Represents the voluntary surrender, without consideration, to the registrant of 11,307,527 shares of Class B Common Stock.